Letter

Statins and outcomes in patients with pneumonia

BMJ 2006; 333 doi: 10.1136/bmj.39038.509167.1F (Published 23 November 2006)
Cite this as: BMJ 2006;333:1123.4

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Not only healthy user bias

  1. Eric M Mortensen (mortensene@uthscsa.edu),
  2. Marcos I Restrepo, assistant professor of medicine,
  3. Laurel A Copeland, assistant professor of psychiatry,
  4. Mary Jo V Pugh, assistant professor of medicine,
  5. Antonio Anzueto, professor of medicine
  1. 1University of Texas Health Science Center at San Antonio, 7400 Merton Minter Boulevard (11C6), San Antonio, TX 78229, USA

    We read with interest the article on the use of statins for patients with pneumonia.1 Although an important addition to the literature, several issues limit this article's usefulness.

    The choice of an outcome measure combining in-hospital mortality and admission to intensive care is curious for a prospective study with such a rich clinical database. Previous research shows that 30 day mortality …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular